Concomitant radio-chemotherapy in invasive bladder tumors;Radiochimiotherapie concomitante des tumeurs infiltrantes de vessie

Bulletin du Cancer

Volumn 84, Issue 4, 1997, Pages 405-411

  Mottet, Nicolas ^a   Di Palma, Mario ^c   Avances, Christophe ^a   Costa, Pierre ^a   Jardin, Alain ^b   Misset, Jean Louis ^c  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

bladder cancer; chemotherapy; cisplatin; combined treatment; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; METHOTREXATE; VINBLASTINE;

BLADDER CANCER; CANCER INVASION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; REVIEW; BLADDER TUMOR; CANCER STAGING; CLINICAL TRIAL; METASTASIS; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0030611963     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Brantley Thrasher J, Frazier HA, Roberston JE, Dodge RK, Paulson DF. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994; 73: 1708-15.
2. Pagano F, Bassi P, Pryer Galetti T, Meneghini A, Milani C, Artibani W, Garbeglio A. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145: 45-50.
3. Hall RR. The role of transurethral surgery alone and with combined modality therapy. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, eds. Comprehensive textbook of Genitourinary Oncology. Baltimore: Williams and Wilkins, 1996: 509-13.
4. Lerner SP, Skinner DG. Radical cystectomy for bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, eds. Comprehensive textbook of Genitourinary Oncology. Baltimore: Williams and Wilkins, 1996; 443-63.
5. Lipponen PK, Eskelinen MJ, Kiviranta J, Pesonen E. Prognosis of transitional cell bladder cancer: a multivariate prognosis score for improved prediction. J Urol 1991; 146: 1535-40.
6. Herr J. Uncertainty, stage and outcome of invasive bladder cancer. J Urol 1994; 152: 401-2.
7. Tsujihashi H, Nakanishi A, Matsuda H, Uejima S, Matsuura T, Akiyama T, Kurita T. Clinical assessment for 152 total cysto-urethrectomized bladder cancers. Jap J Urol 1989; 80: 1632-7.
8. Waehre H, Ous S, Klevmark B, Kvarstein B, Urnes T, Ogreid P, et al. A bladder cancer multi-institutional experience with total cystectomy for muscle invasive bladder cancer. Cancer 1993; 72: 3044-51.
9. Frazier HAJ, Roberston JE, Dodge RK, Paulson DF. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1993; 71: 3993-4001.
10. Lerner SP, Skinner DG, Lieskovsky G, Boyd SD, Groshen SL, Ziogas A, et al. The rational for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases. Long term survival. J Urol 1993; 149: 758-65.
11. Vieweg J, Whitmore WF, Jr, Heer HW. The role of pelvic lymphadenectomy for lymph node positive bladder cancer. Cancer 1994; 73: 3020-8.
12. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 16: 83-101.
13. Eapen L, Stewert D, Crook J, Huan S, Aref I, Segal R, et al. Intraarterial cisplatin and concurrent pelvic radiation in the management of transitional bladder cancer. An organ preservation strategy [Abstract]. Proc Am Soc Clin Oncol 1995; 14: 238.
14. Miyanaga N, Akaza H, Ohtani M, Takeshima H, Uehida K, Kikuchi K, Kawai K. A bladder sparing regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer [Abstract]. J Urol 1996; 155: 664A.
15. Housset M, Maulard C, Chretien Y, Dufour B, Delanian S, Huart J, et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993; 11: 2150-7.
16. Housset M, Dufour B, Maulard C, Chretien Y, Hallez JP, Delanian S, Baillet F. Combined 5-FU, Cisplatin and accelerated split course irradiation for invasive transitional-cell carcinoma of the bladder. Int J Rad Oncol Biol Phys 1994; 30: 201.
17. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 1993; 329: 1377-82.
18. Russel KJ, Boileau MA, Higano C, Collins C, Russel AH, Koh W, et al. Combined 5-Fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Rad Oncol Biol Phys 1990; 19: 693-9.
19. Tester W, Porter A, Asbell S, Coughlin C, Heaney J, Ktall J, et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Rad Oncol Biol Phys 1993; 25: 783-90.
20. Tester W, Caplan R, Heany J, Venner P, Whittington R, Byhardt R, et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of radiation therapy oncology group phase II trial 8802. J Clin Oncol 1996; 14: 119-26.
21. Shipley WU, Prout GR, Einstein AB, Coombs J, Wajsman Z, Soloway MS, et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 1987; 258: 931-5.
22. Who handbook for reporting results of cancer treatment. Who offset publication no 48. Neoplasia 1980; 20: 37-46.
23. Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Vincent P, Choquenet C, Reboul F. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. J Urol 1996; 156: 1258-63.
24. See WA, Fuller JR. Staging of advanced bladder cancer. Current concepts and pitfalls. Urol Clin North Amer 1992; 19: 663-83.
25. Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996; 155: 495-500.
26. Hall RR. Neo-adjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer. First analysis of MRC/EORTC intercontinental trial [Abstract]. Proc Am Soc Clin Oncol 1996; 15: 244.
27. Sackett DL. How to read clinical journals. CMA Journal 1981; 124: 555-90.
28. Kachnic LA, Kaufman DS, Zietman AL, Dallow KC, Griffin PP, Heney NM, et al. Selective bladder preservation by combined modality therapy for invasive bladder cancer. Int J Rad Oncol Biol Phys 1995; 32: 271.